USPTO Examiner LAM ELIZA ANNE - Art Unit 3681

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18824511METHODS AND SYSTEMS FOR DETERMINING HEALTH OF AN ORGAN BASED ON MEDICAL IMAGE DATA USING ARTIFICIAL INTELLIGENCESeptember 2024February 2025Allow511YesNo
18433199MANAGEMENT OF PHARMACY KITS USING MULTIPLE ACCEPTANCE CRITERIA FOR PHARMACY KIT SEGMENTSFebruary 2024June 2025Allow1610NoNo
18417247Systems and Methods for Computing Measurements for Mitochondrial DiseasesJanuary 2024March 2025Abandon1410NoNo
18514211SYSTEM AND METHOD FOR SAFE AND ACCURATE SELF ADMINISTRATION OF MEDICATIONSNovember 2023March 2025Allow1620NoNo
18142411APPARATUS FOR POST ACTION PLANNING AND METHOD OF USEMay 2023November 2024Allow1830YesNo
18304278DIAGNOSTIC COMMUNICATION SYSTEMS, DIAGNOSTIC DATA COLLECTION KITS, AND METHODS FOR GENERATING AND CONVEYING ORAL CONDITION DATA SETS AND TREATMENT PLANSApril 2023February 2025Abandon2210NoNo
18248271REMOTE VENTILATION DASHBOARD SYSTEMApril 2023June 2025Abandon2710NoNo
18109919Circadian Rhythm Recommendation Model Using Light Sensors and an Intelligent Light BoxFebruary 2023April 2025Abandon2610NoNo
18108279HEALTHCARE DELIVERY SYSTEMFebruary 2023June 2025Abandon2830NoNo
18157799SYSTEMS AND METHODS FOR SELECTING A SCANNING DEVICE FOR AN OBJECTJanuary 2023June 2025Allow2910NoNo
18156909PREDICTING TOLERABILITY IN AGGRESSIVE NON-HODGKIN LYMPHOMAJanuary 2023May 2025Allow2810YesNo
17989046COPD MONITORINGNovember 2022May 2025Abandon3010NoNo
17964427SYSTEM AND METHOD FOR SIMULTANEOUS GENERATION OF ELECTRONIC MEDICAL RECORDS FOR ARTIFICIAL INTELLIGENCE-ENABLED DYNAMIC IMAGE RECOGNITIONOctober 2022February 2025Abandon2810NoNo
17937054WIRELESS CHARGING OF MEDICAL DEVICESSeptember 2022December 2024Allow2610NoNo
17954113COMPUTING DEVICES PROGRAMMED FOR DYNAMIC ACTIVITY-ASSIGNMENT PROCESSING VIA WEARABLE DEVICES AND METHODS/SYSTEMS OF USE THEREOFSeptember 2022December 2024Abandon2630NoNo
17887818PREDICTIVE AND INTERACTIVE DIAGNOSTIC SYSTEMAugust 2022August 2024Allow2450YesNo
17885714Automated Summarization of a Hospital Stay Using Machine LearningAugust 2022September 2024Allow2510NoNo
17681570UNIFIED DATA INTERFACE AND SYSTEMFebruary 2022August 2023Allow1840YesNo
17575905SYSTEM AND METHOD FOR RANKING OPTIONS FOR MEDICAL TREATMENTSJanuary 2022April 2025Allow3940NoYes
17619741DIAGNOSIS SUPPORT PROGRAM, DIAGNOSIS SUPPORT SYSTEM, AND DIAGNOSIS SUPPORT METHODDecember 2021December 2024Abandon3610NoNo
17541399SYSTEMS AND METHODS FOR GENERATING A CANCER ALLEVIATION NOURISHMENT PLANDecember 2021May 2025Allow4110YesNo
17393113ENSEMBLE MACHINE-LEARNING MODELS TO DETECT RESPIRATORY SYNDROMESAugust 2021June 2025Allow4630NoNo
17385672LOCATION-AWARE WELL-BEING INSIGHTSJuly 2021November 2024Allow4040YesNo
17380059SMART NUTRITION DOSINGJuly 2021October 2024Allow3940YesNo
17414519COUNSELING METHOD AND COUNSELING DEVICEJune 2021October 2024Allow4030YesNo
17144406BEHAVIOR MODIFICATION ASSISTANCE DEVICE, TERMINAL, AND SERVERJanuary 2021May 2025Abandon5340YesNo
17136084SYSTEMS AND METHODS FOR GENERATING A CANCER ALLEVIATION NOURISHMENT PLANDecember 2020May 2025Allow5280YesNo
16862643METHOD FOR ADJUSTING A BOLUS AMOUNT OF INSULIN, DEVICE AND MEDICAL SYSTEMApril 2020June 2024Allow5030YesNo
15872977DIALYSIS DEVICEJanuary 2018April 2020Allow2700NoNo
15670475ELECTRONIC HEALTH RECORD WEB-BASED PLATFORMAugust 2017December 2024Abandon6070NoNo
15592071METHODS AND DEVICES FOR REDUCING TRANSFUSIONS DURING OR AFTER SURGERY AND FOR IMPROVING QUALITY OF LIFE AND FUNCTION IN CHRONIC DISEASEMay 2017July 2024Allow6090NoNo
15395646SYSTEMS AND METHODS FOR GENERATING ELECTRONIC COMMUNICATIONS AND UPDATING ELECTRONIC DATABASESDecember 2016March 2024Allow60130YesNo
15142130SMART FITNESS TRACKERApril 2016May 2017Allow1211YesNo
14836218Healthcare Facility Management and Information SystemAugust 2015November 2018Allow3910NoNo
14800318USER FRIENDLY MEDICAL RECORDS SYSTEMS, APPARATUSES AND METHODSJuly 2015April 2020Allow5730NoNo
12215696COMPLIANCE DATA FOR HEALTH-RELATED PROCEDURESJune 2008November 2011Allow4020NoYes
12080426GENERATING OUTPUT DATA BASED ON PATIENT MONITORINGApril 2008November 2011Allow4320NoYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LAM, ELIZA ANNE.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
3
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
99.4%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner LAM, ELIZA ANNE - Prosecution Strategy Guide

Executive Summary

Examiner LAM, ELIZA ANNE works in Art Unit 3681 and has examined 34 patent applications in our dataset. With an allowance rate of 70.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner LAM, ELIZA ANNE's allowance rate of 70.6% places them in the 25% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by LAM, ELIZA ANNE receive 3.00 office actions before reaching final disposition. This places the examiner in the 95% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LAM, ELIZA ANNE is 36 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +35.2% benefit to allowance rate for applications examined by LAM, ELIZA ANNE. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 16.7% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 20.0% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 98% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 98% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 5% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 36% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 36% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.